Protein catabolism in advanced renal disease: Role of cytokines

Clinical Nephrology

Volumn 70, Issue 2, 2008, Pages 91-100

  Fleet, M ^a   Osman, F ^a   Komaragiri, R ^a   Fritz, A ^a   Raj, D S C ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

Acute phase proteins; Catabolism and nutrition; Hemodialysis; Inflammation

Indexed keywords

ALBUMIN; ALDEHYDE DERIVATIVE; BORONIC ACID DERIVATIVE; CALPAIN; CATHEPSIN; CYTOKINE; CYTOKINE ANTIBODY; ENDOTOXIN; FIBRINOGEN; GLUCOCORTICOID; ICOSAPENTAENOIC ACID; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; LACTACYSTIN; LEPTIN; LEUCINE; LIVER PROTEIN; MESSENGER RNA; MUSCLE PROTEIN; MUSCLE RING FINGER 1 PROTEIN; MYOD PROTEIN; MYOSTATIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEASOME INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN; VINYL SULFONE;

AMINO ACID DEFICIENCY; BIOCOMPATIBILITY; CACHEXIA; CHRONIC KIDNEY DISEASE; CYTOKINE PRODUCTION; DIALYSATE; DIET SUPPLEMENTATION; DRUG MECHANISM; ENZYME ACTIVATION; HEMODIALYSIS; HUMAN; IMMUNOREGULATION; INNATE IMMUNITY; INTRADIALYTIC PARENTERAL NUTRITION; KIDNEY FAILURE; KIDNEY FUNCTION; LEAN BODY WEIGHT; MALNUTRITION; MEDLINE; MUSCLE ATROPHY; MUSCLE METABOLISM; NONHUMAN; NUTRIENT SUPPLY; NUTRITIONAL COUNSELING; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN SECRETION; PROTEIN SYNTHESIS; REVIEW;

EID: 48749132330     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp70091     Document Type: Review

References (103)

1. Acharyya S, Ladner KJ, Nelsen LL, Damrauer J, Reiser PJ, Swoap S, Guttridge DC. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest. 2004; 114: 370-378.
2. Adey D, Kumar R, McCarthy JT, Nair KS. Reduced synthesis of muscle proteins in chronic renal failure. Am J Physiol. 2000; 278: E219-E225.
3. Baliga R, George VT, Ray PE, Holliday MA. Effects of reduced renal function and dietary protein on muscle protein synthesis. Kidney Int. 1991; 39: 831-835.
4. Barber MD, Ross JA, Voss AC, Tisdale MJ, Fearon KC. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer. 1999; 81: 80-86.
5. Barle H, Januszkiewicz A, Hallstrom L, Essen P, McNurlan Ma, Garlick PJ, Wernerman J. Albumin synthesis in humans increases immediately following the administration of endotoxin. Clin Sci. 2002; 103: 525-531.
6. Bergstrom J. Nutrition and mortality in hemodialysis. J Am Soc Nephrol. 1995; 6: 1329-1341.
7. Bergstrom J, Lindholm B, Lacson EJ, Owen WJ, Lowrie EG, Glassock RJ, Ikizler TA, Wessels FJ, Moldawer LL, Wanner C, Zimmermann J. What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients? Semin Dial. 2000; 13: 163-175.
8. Berkelhammer CH, Baker JP, Leiter LA, Uldall PR, Whittall R, Slater A, Wolman SL. Whole-body protein turnover in adult hemodialysis patients as measured by 13C-leucine. Am J Clin Nutr. 1987; 46: 778-783.
9. Biolo G, Tipton KD, Klein S, Wolfe RR. An abundant supply of amino acids enhances the metabolic effect of exercise on muscle protein. Am J Physiol. 1997; 273: E122-E129.
10. Biolo G, Toigo G, Ciocchi B, Morena G, Situlin R, Vasile A, Carraro M, Faccini L, Guarnieri G. Relationship between whole-body protein turnover and serum creatinine in chronically uremic patients. Miner Electrolyte Metab. 1998; 24: 267-272.
11. Biolo G, Ciocchi B, Bosutti A, Situlin R, Toigo G, Guarnieri G. Pentoxifylline acutely reduces protein catabolism in chronically uremic patients. Am J Kidney Dis. 2002; 40: 1162-1172.
12. Bogdanovich S, Krag TO, Barton ER, Morris LD, Whittemore LA, Ahima RS, Khurana TS. Functional improvement of dystrophic muscle by myostatin blockade. Nature. 2002; 420: 418-421.
13. Bommer J, Becker KP, Urbaschek R. Potential transfer of endotoxin across high-flux polysulfone membranes. J Am Soc Nephrol. 1996; 7: 883-888.
14. Caglar K, Peng Y, Pupim LB, Flakoll PJ, Levenhagen D, Hakim RM, Ikizler TA. Inflammatory signals associated with hemodialysis. Kidney Int. 2002; 62: 1408-1416.
15. Carlson CJ, Booth FW, Gordon SE. Skeletal muscle myostatin mRNA expression is fiber-type specific and increases during hindlimb unloading. Am J Physiol. 1999; 277: R601-R606.
16. Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology. 1990; 12: 1179-1186.
17. Castellino P, Luzi L, Simonson DC, Haymond M, DeFronzo RA. Effect of insulin and plasma amino acid concentrations on leucine metabolism in man. Role of substrate availability on estimates of whole-body protein synthesis. J Clin Invest. 1987; 80: 1784-1793.
18. Castellino P, Solini A, Luzi L, Barr JG, Smith DJ, Petrides A, Giordano M, Carroll C, De Fronzo RA. Glucose and amino acid metabolism in chronic renal failure: effect of insulin and amino acids. Am J Physiol. 1992; 262: F168-F176.
19. Conley SB, Rose GM, Robson AM, Bier DM. Effects of dietary intake and hemodialysis on protein turnover in uremic children. Kidney Int. 1980; 17: 837-846.
20. De Feo P, Horber FF, Haymond MW. Meal stimulation of albumin synthesis: a significant contributor to whole-body protein synthesis in humans. Am J Physiol. 1992; 263: E794-E799.
21. Deval C, Mordier S, Obled C, Bechet D, Combaret L, Attaix D, Ferrara M. Identification of cathepsin L as a differentially expressed message associated with skeletal muscle wasting. Biochem J. 2001; 360: 143-150.
22. Du J, Mitch WE, Wang X, Price SR. Glucocorticoids induce proteasome C3 subunit expression in L6 muscle cells by opposing the suppression of its transcription by NE-κB. J Biol Chem. 2000; 275: 19661-19666.
23. Du J, Wang X, Miereles C, Bailey JL, Debigare R, Zheng B, Price SR, Mitch WE. Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. J Clin Invest. 2004; 113: 115-123.
24. Fearon KC, Von Meyenfeldt MF, Moses AG, Van Geenen R, Roy A, Gouma DJ, Giacosa A, Van Gossum A, Bauer J, Barber MD, Aaronson NK, Voss AC, Tisdale MJ. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double-blind trial. Gut. 2003; 52: 1479-1486.
25. Febbraio MA, Steensberg A, Keller C, Starkie RL, Nielsen HB, Krustrup P, Ott P, Secher NH, Pedersen BK. Glucose ingestion attenuates interleukin-6 release from contracting skeletal muscle in humans. J Physiol. 2003; 549: 607-612.
26. Flores EA, Bistrian BR, Pomposelli JJ, Dinarello CA, Blackburn GL, Istfan NW. Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin 1. J Clin Invest. 1989; 83: 1614-1622.
27. Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, Franch H, Guarnieri G, Ikizler TA, Kaysen G, Lindholm B, Massy Z, Mitch W, Pineda E, Stenvinkel P, Thevinho-Becerra A, Wanner C. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008; 73: 391-398.
28. Fu A, Sreekumaran N. Age effect on fibrinogen and albumin synthesis in humans. Am J Physiol. 1998; 275: E1023-E1030.
29. Fujita J, Tsujinaka T, Yano M, Ebisui C, Saito H, Katsume A, Akamatsu K, Ohsugi Y, Shiozaki H, Monden M. Anti-interleukin-6 receptor antibody prevents muscle atrophy in colon-26 adenocarcinoma-bearing mice with modulation of lysosomal and ATP-ubiquitin-dependent proteolytic pathways. Int J Cancer. 1996; 68: 637-643.
30. Gerber AJ. Skeletal muscle protein and amino acid metabolism in experimental chronic uremia in the rat. Accelerated alanine and glutamine formation and release. J Clin Invest. 1978; 62: 623-632.
31. Garibotto G, Barreca A, Russo R, Sofia A, Araghi P, Cesarone A, Malaspina M, Fiorini F, Minuto F, Tizianello A. Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients. J Clin Invest. 1997; 99: 97-105.
32. Giordano M, De F, Lucidi P, DePascale E, Giordano G, Infantone L, Zoccolo AM, Castellino P. Increased albumin and fibrinogen synthesis in hemodialysis patients with normal nutritional status. J Am Soc Nephrol. 2001; 12: 349-354.
33. Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci USA. 2001; 98: 14440-14445.
34. Gonzalez-Cadavid NF, Taylor WE, Yarasheski K, Sinha-Hikim I, Ma K, Ezzat S, Shen R, Lalani R, Asa S, Mamita M, Nair G, Arver S, Bhasin S. Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. Proc Natl Acad Sci USA. 1998; 95: 14938-14943.
35. Goodship TH, Lloyd S, Clague MB, Bartlett K, Ward MK, Wilkinson R. Whole-body leucine turnover and nutritional status in continuous ambulatory peritoneal dialysis. Clin Sci. 1987; 73: 463-469.
36. Grossman SB, Yap SH, Shafritz DA. Influence of chronic renal failure on protein synthesis and albumin metabolism in rat liver. J Clin Invest. 1977; 59: 869-878.
37. Grunfeld C, Zhao C, Fuller J, Pollack A, Moser A, Friedman J, Feingold KR. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest. 1996; 97: 2152-2157.
38. Gutierrez A, Alvestrand A, Wahren J, Bergstrom J. Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans. Kidney Int. 1990; 38: 487-494.
39. Guttridge DC, Mayo MW, Madrid LV, Wang CY, Baldwin AS Jr. NFκB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science. 2000; 289: 2363-2366.
40. Halliday D, McKeran RO. Measurement of muscle protein synthetic rate from serial muscle biopsies and total body protein turnover in man by continuous intravenous infusion of L-(α-15N)lysine. Clin Sci Mol Med. 1975; 49: 581-590.
41. Hou JC, Zhou JN, Zhu HW, Wu JZ, Wu JC, Zhang MW. Dynamic aspects of whole-body nitrogen metabolism in uremic patients on dietary therapy. Nephron. 1986; 44: 288-294.
42. Huang J, Forsberg NE. Role of calpain in skeletal-muscle protein degradation. Proc Natl Acad Sci USA. 1998; 95: 12100-12105.
43. Ikizler TA, Pupim LB, Brouillette JR, Levenhagen DK, Farmer K, Hakim RM, Flakoll PJ. Hemodialysis stimulates muscle and whole-body protein loss and alters substrate oxidation. Am J Physiol. 2002; 282: E107-E116.
44. Jackman RW, Kandarian SC. The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol. 2004; 287: C834-C843.
45. Jahoor F, Wykes L, Del Rosario M, Frazer M, Reeds PJ. Chronic protein undernutrition and an acute inflammatory stimulus elicit different protein kinetic responses in plasma but not in muscle of piglets. J Nutr. 1999; 129: 693-699.
46. Kaliman P, Canicio J, Testar X, Palacin M, Zorzano A. Insulin-like growth factor-II, phosphatidylinositol 3-kinase, nuclear factor-κB and inducible nitric-oxide synthase define a common myogenic signaling pathway. J Biol Chem. 1999; 274: 17437-17444.
47. Kaysen GA, Chertow GM, Adhikarla R, Young B, Ronco C, Levin NW. Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients. Kidney Int. 2001; 60: 333-340.
48. Kaysen GA, Dubin JA, Muller HG, Mitch WE, Rosales LM, Levin NW. Relationships among inflammation nutrition and physiologic mechanisms establishing albumin levels in hemodialysis patients. Kidney Int. 2002; 61: 2240-2249.
49. Kaysen GA, Schoenfeld PY. Albumin homeostasis in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int. 1984; 25: 107-114.
50. Kimmel PL, Phillips TM, Simmens SJ, Peterson RA, Weihs KL, Alleyne S, Cruz I, Yanovski JA, Veis JH. Immunologic function and survival in hemodialysis patients. Kidney Int. 1998; 54: 236-244.
51. Kisselev AF, Goldberg AL. Proteasome inhibitors: from research tools to drug candidates. Chem Biol. 2001; 8: 739-758.
52. Kopple JD. McCollum Award Lecture 1996: Protein-energy malnutrition in maintenance dialysis patients. Am J Clin Nutr. 1997; 65: 1544-1557.
53. Kopple JD, Monteon FJ, Shaib JK. Effect of energy intake on nitrogen metabolism in nondialyzed patients with chronic renal failure. Kidney Int. 1986; 29: 734-742.
54. Laude-Sharp M, Caroff M, Simard L, Pusineri C, Kazatchkine MD, Haeffner-Cavaillon N. Induction of IL-1 during hemodialysis: transmembrane passage of intact endotoxins (LPS). Kidney Int. 1990; 38: 1089-1094.
55. Lee SW, Dai G, Hu Z, Wang X, Du J, Mitch WE. Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase. J Am Soc Nephrol. 2004; 15: 1537-1545.
56. Li YP, Lecker SH, Chen Y, Waddell ID, Goldberg AL, Reid MB. TNF-α increases ubiquitin-conjugating activity in skeletal muscle by upregulating UbcH2/E220k. FASEB J. 2003; 17: 1048-1057.
57. Lim VS, Bier DM, Flanigan MJ, Sum-Ping ST. The effect of hemodialysis on protein metabolism. A leucine kinetic study. J Clin Invest. 1993; 91: 2429-2436.
58. Lim VS, Ikizler TA, Raj DS, Flanigan MJ. Does hemodialysis increase protein breakdown? Dissociation between whole-body amino acid turnover and regional muscle kinetics. J Am Soc Nephrol. 2005; 16: 862-868.
59. Loder PB, Smith RC, Kee AJ, Kohlhardt SR, Fisher MM, Jones M, Reeve TS. What rate of infusion of intravenous nutrition solution is required to stimulate uptake of amino acids by peripheral tissues in depleted patients? Ann Surg. 1990; 211: 360-368.
60. Loprinzi CL, Schaid DJ, Dose AM, Burnham NL, Jensen MD. Body-composition changes in patients who gain weight while receiving megestrol acetate. J Clin Oncol. 1993; 11: 152-154.
61. Ma K, Mallidis C, Artaza J, Taylor W, Gonzalez-Cadavid N, Bhasin S. Characterization of 5′-regulatory region of human myostatin gene: regulation by dexamethasone in vitro. Am J Physiol. 2001; 281: E1128-E1136.
62. Ma K, Mallidis C, Bhasin S, Mahabadi V, Artaza J, Gonzalez-Cadavid N, Arias J, Salehian B. Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am J Physiol. 2003; 285: E363-E371.
63. Mayer RJ. The meteoric rise of regulated intracellular proteolysis. Nat Rev Mol Cell Biol. 2000; 1: 145-148.
64. McMillan DC, Slater C, Preston T, Falconer JS, Fearon KC. Simultaneous measurement of albumin and fibrinogen synthetic rates in normal fasted subjects. Nutrition. 1996; 12: 602-607.
65. Mitch WE. Malnutrition: a frequent misdiagnosis for hemodialysis patients. J Clin Invest. 2002; 110: 437-439.
66. Moshage HJ, Janssen JA, Franssen JH, Hafkenscheid JC, Yap SH. Study of the molecular mechanism of decreased liver synthesis of albumin in inflammation. J Clin Invest. 1987; 79: 1635-1641.
67. Panichi V, Migliori M, De Pietro S, Taccola D, Andreini B, Metelli MR, Giovannini L, Palla R. The link of biocompatibility to cytokine production. Kidney Int. 2000; 58 (Suppl 76): S96-S103.
68. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 1995; 269: 540-543.
69. 2-microglobulin. Nephrol Dial Transplant. 1991; 6 (Suppl 2): S18-S23.
70. Pertosa G, Tarantino EA, Gesualdo L, Montinaro V, Schena FP. C5b-9 generation and cytokine production in hemodialyzed patients. Kidney Int. 1993; (Suppl 41): S221-S225.
71. Pierratos A, Ouwendyk M, Vas S, Francoeur R, Raj DSC, Ecclestone A, Logos V, Uldall R. Nocturnal hemodialysis: three years experience. J Am Soc Nephrol. 1998; 9: 859-868.
72. Pupim LB, Flakoll PJ, Brouillette JR, Levenhagen DK, Hakim RM, Ikizler TA. Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic hemodialysis patients. J Clin Invest. 2002; 110: 483-492.
73. Pupim LB, Flakoll PJ, Ikizler TA. Nutritional supplementation acutely increases albumin fractional synthetic rate in chronic hemodialysis patients. J Am Soc Nephrol. 2004; 15: 1920-1926.
74. Raj DSC, Ouwendyk M, Francoeur R, Logos V, Eccllestone A, Pierratos A. Serum amino acid profile in nocturnal hemodialysis. Blood Purif 2000; 18: 97-102.
75. Raj DSC, Welbourne T, Dominic EA, Waters D, Wolfe R, Ferrando A. Glutamine kinetics and protein turnover in end-stage renal disease. Am J Physiol Endocrinol Metab. 2004a; 288: E37-E46.
76. Raj DSC, Zager P, Shah VO, Dominic EA, Adeniyi O, Blandon P, Wolfe R, Ferrando A. Protein turnover and amino acid transport kinetics in end-stage renal disease. Am J Physiol Endocrinol Metab. 2004b; 286: E136-E143.
77. Raj DSC, Dominic EA, Wolfe RA, Shah VO, Bankhurst A, Zager P, Ferrando A. Coordinated increase in albumin, fibrinogen and muscle protein synthesis during hemodialysis: role of cytokines. Am J Physiol. 2004c; 286: E658-E664.
78. Raj DSC, Dominic EA, Pai A, Osman F, Morgan M, Pickett G, Shah VO, Ferrando A, Moseley P. Skeletal muscle, cytokines and oxidative stress in end-stage renal disease, Kidney Int. 2005; 68: 2338-2344.
79. Raj DSC, Adeniyi O, Dominic EA, Boivin MA, McClelland S, Tzamaloukas AH, Morgan N, Gonzales L, Wolfe R, Ferrando A. Amino acid repletion does not decrease muscle protein catabolism during hemodialysis. Am J Physiol. 2007a; 292: E1534-E1542.
80. Raj DSC, Boivin MA, Dominic EA, Boyd A, Roy PK, Rihani T, Tzamaloukas AH, Shah VO, Moseley P. Hemodialysis induces mitochondrial dysfunction and apoptosis. Eur J Clin Invest. 2007b; 37: 971-977.
81. Raj DSC, Adeniyi O, Dominic EA, Boivin MA, McClelland S, Tzamaloukas AH, Morgan N, Gonzales L, Wolf R, Ferrando A. Amino acid repletion does not decrease muscle protein catabolism during hemodialysis. Am J Physiol Endocrinol. 2007c; Metab 292: E1534-E1542.
82. Raj DSC, Moseley P, Dominic EA, Onime A, Tzamaloukass AH, Boyd A, Shah VO, Glew R, Wolfe R, Ferrando A. Interleukin-6 modulates hepatic and muscle protein synthesis during hemodialysis. Kidney Int. 2008; (in press).
83. Rammohan M, Kalantar-Zadeh K, Liang A, Ghossein C. Megestrol acetate in a moderate dose for the treatment of malnutrition-inflammation complex in maintenance dialysis patients. J Ren Nutr. 2005; 15: 345-355.
84. Reid MB, Li YP. Tumor necrosis factor-α and muscle wasting: acellular perspective. Respir Res. 2001; 2: 269-272.
85. Roccatello D, Menegatti E, Alfieri V, Rossi D, DeLuca A, Pignone E, Mengozzi G, Cesano G, Formica M, Martina G, Sena LM, Piccoli G. Intradialytic cytokine gene expression. Blood Purif. 1998; 16: 30-36.
86. Sakurai Y, Zhang XJ, Wolfe RR. Effect of tumor necrosis factor on substrate and amino acid kinetics in conscious dogs. Am J Physiol. 1994; 266: E936-E945.
87. Sakurai Y, Zhang XJ, Wolfe RR. TNF directly stimulates glucose uptake and leucine oxidation and inhibits FFA flux in conscious dogs. Am J Physiol. 1996; 270: E864-E872.
88. Shah V, Dominic EA, Moseley P, Picket G, Fleet M, Ness S, Raj DSC. Hemodialysis modulates gene expression profile in skeletal muscle. Am J Kidney Dis. 2006; 48: 628.
89. Steensberg A, Febbraio MA, Osada T, Schjerling P, van Hall G, Saltin B, Pedersen BK. Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content. J Physiol. 2001; 537: 633-639.
90. Steinfeld JL. Albumin synthesis and degradation in patients with cancer. Proc Natl Cancer Conf. 1964; 5: 401-409.
91. Streat SJ, Beddoe AH, Hill GL. Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients. J Trauma. 1987; 27: 262-266.
92. Taylor WE, Bhasin S, Artaza J, Byhower F, Azam M, Willard DH Jr, Kull FC Jr, Gonzalez-Cadavid N. Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells. Am J Physiol. 2001; 280: E221-E228.
93. Tisdale MJ. Molecular pathways leading to cancer cachexia. Physiology (Bethesda). 2005; 20: 340-348.
94. Tsujinaka T, Ebisui C, Fujita J, Kishibuchi M, Morimoto T, Ogawa A, Katsume A, Ohsugi Y, Kominami E, Monden M. Muscle undergoes atrophy in association with increase of lysosomal cathepsin activity in interleukin-6 transgenic mouse. Biochem Biophys Res Commun. 1995; 207: 168-174.
95. Volpi E, Lucidi P, Cruciani G, Monacchia F, Reboldi G, Brunetti P, Bolli GB, De Feo P. Contribution of amino acids and insulin to protein anabolism during meal absorption. Diabetes. 1996; 45: 1245-1252.
96. Waterlow JC, Garlick PJ, Millward DJ. Protein turnover in mammalian tissues and in whole-body. New York: Elsevier/North-Holland; 1978. p. 117-176.
97. Watt PW, Corbett ME, Rennie MJ. Stimulation of protein synthesis in pig skeletal muscle by infusion of amino acids during constant insulin availability. Am J Physiol. 1992; 263: E453-E460.
98. Weigle DS, Bukowski TR, Foster DC, Holderman S, Kramer JM, Lasser G, Lofton-Day CE, Prunkard DE, Raymond C, Kuijper JL. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J Clin Invest. 1995; 96: 2065-2070.
99. Whitehouse AS, Smith HJ, Drake JL, Tisdale MJ. Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid. Cancer Res. 2001; 61: 3604-3609.
100. Wigmore SJ, Barber MD, Ross JA, Tisdale MJ, Fearon KC. Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutr Cancer. 2000; 36: 177-184.
101. Workeneh BT, Rondon-Berrios H, Zhang L, Hu Z, Ayehu G, Ferrando A, Kopple JD, Wang H, Storer T, Fournier M, Lee SW Du J, Mitch WE. Development of a diagnostic method for detecting increased muscle protein degradation in patients with catabolic conditions. J Am Soc Nephrol. 2006; 17: 3233-3239.
102. Zamir O, O'Brien W, Thompson R, Bloedow DC, Fischer JE, Hasselgren PO. Reduced muscle protein breakdown in septic rats following treatment with interleukin-1 receptor antagonist. Int J Biochem. 1994; 26: 943-950.
103. Zimmers TA, Davies MV, Koniaris LG, Haynes P, Esquela AF, Tomkinson KN, McPherron AC, Wolfman NM, Lee SJ. Induction of cachexia in mice by systemically administered myostatin. Science. 2002; 296: 1486-1488.